Skip to content
POM-V Prescription Required Companion Animal

VetUK Cat Wormer 4 mg/10 mg Film-coated Tablets for Small Cats and Kittens

Active ingredients: Milbemycin Oxime (A3 and A4), Praziquantel

Form

Tablet

Species

Cats

Manufacturer

Alfamed

VMD MA No.

17902/3013

What it's used for

Nematodes: Ancylostoma tubaeforme, Toxocara cati Prevention of heartworm disease (Dirofilaria immitis), if concomitant treatment against cestodes is indica...

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Milbemycin Oxime (A3 and A4)...

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

VetUK Cat Wormer 4 mg/10 mg Film-coated Tablets for Small Cats and Kittens — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Nematodes:
Ancylostoma tubaeforme,
Toxocara cati
Prevention of heartworm disease (Dirofilaria immitis), if concomitant treatment against
cestodes is indicated.
To ensure a correct dosage, body weight should be determined as accurately as possible.
Minimum recommended dose rate: 2 mg of milbemycin oxime and 5 mg of praziquantel
per kg are given once orally as a single dose.
The veterinary medicinal product should be administered with or after some food.
The veterinary medicinal product is a small size tablet.
To aid with administration, the veterinary medicinal product has been coated with a meat
flavour.
The tablets can be divided into halves.
Depending on the bodyweight of the cat, the practical dosing is as follows:
WeightTablets0.5 - 1 kg1/2 tablet> 1 – 2 kg1 tablet
The veterinary medicinal product can be inserted into a programme for prevention of
heartworm disease if at the same time treatment against tapeworms is indicated. The
veterinary medicinal product has a duration of heartworm prevention of one month. For
prevention of heartworm disease the use of a monosubstance is preferred.
Do not use in kittens of less than 6 weeks of age and/or weighing less than 0.5 kg.
Do not use in cases of hypersensitivity to the active substances or to any of the excipients.
Cats (small cats and kittens):
Very rare
(<1 animal / 10,000 animals treated, including
isolated reports):
Hypersensitivity reaction
Systemic disorders
(e.g. Lethargy)
Neurological disorders
(e.g. Ataxia,
Muscle tremor)
Digestive tract disorders
(e.g. Emesis,
Diarrhoea)
Especially in young cats.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
AN: 03456/2024Page 4 of 7
It is recommended to treat all the animals living in the same household concomitantly.
In order to develop an effective worm control programme local epidemiological information
and the living conditions of the cat should be taken into account and therefore it is
recommended to seek professional advice.
Parasite resistance to any particular class of anthelmintic may develop following frequent,
repeated use of an anthelmintic of that class.
When Dipylidium caninum infection is present, concomitant treatment against intermediate
hosts, such as fleas and lice, should be considered to prevent re-infection.

Special precautions for safe use in the target species:
No studies have been performed with severely debilitated cats or individuals with seriously
compromised kidney or liver function. The veterinary medicinal product is not
recommended for such animals or only according to the benefit-risk assessment by the
responsible veterinarian.
Studies have shown that treatment of dogs with a high number of circulating microfilariae
can sometimes lead to the appearance of hypersensitivity reactions, such as pale mucous
membranes, vomiting, trembling, laboured breathing or excessive salivation. These
reactions are associated with the release of proteins from dead or dying microfilariae and
are not a direct toxic effect of the veterinary medicinal product. In the absence of data on
cats with microfilaraemia, its use should be according to a benefit risk assessment by the
attending veterinarian.
AN: 03456/2024Page 3 of 7
The tablets are flavoured. In order to avoid any accidental ingestion, store tablets out of
reach of the animals.
As per good veterinary practice, animals should be weighed to ensure accurate dosing.
Ensure cats and kittens weighing between 0.5 kg and ≤2 kg receive the appropriate tablet
strength (4 mg MBO/10 mg praziquantel) and the appropriate dose (1/2 or 1 tablet) for the
corresponding weight band (1/2 tablet for cats weighing 0.5 to 1 kg ; 1 tablet for cats
weighing >1 to 2 kg – 1 tablet).
Special precautions to be taken by the person administering the veterinary medicinal
product to animals:
Do not handle this veterinary medicinal product in case of hypersensitivity to the active
substances or to any of the excipients.
Wash hands after use.
Part tablets should be returned to the open blister pack and stored in the carton.
In case of accidental ingestion of the tablets, particularly by a child, seek medical advice
immediately and show the package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.
Other precautions:
Echinococcosis represents a hazard for humans. As Echinococcosis is a notifiable disease
to the World Organisation for Animal Health (WOAH), specific guidelines on the treatment
and follow-up, and on the safeguard of persons, need to be obtained from the relevant
competent authority.
The concurrent use of the combination praziquantel/milbemycin oxime with selamectin is
well tolerated. No interactions were observed when the recommended dose of the
macrocyclic lactone selamectin was administered during treatment with the combination at
the recommended dose. In the absence of further studies, caution should be taken in the
case of concurrent use of the veterinary medicinal product and other macrocyclic lactones.
Also no such studies have been performed with reproducing animals.
This veterinary medicinal product does not require any special temperature storage
conditions.
Half tablets should be stored in the original blister and be used for the next administration.
Keep the blister in the outer carton.
Not applicable.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.